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MATHEMATICAL MODEL OF ETHANOL
METABOLISM IN LIVER

PARAG PANDE
ABSTRACT

A lumped mathematical model of liver metabolism is presented to analyze the
effect of ethanol on metabolic processes of 24 hr fasted rats. The model is developed in
two parts. In the first part individual kinetic models for important regulatory steps in the
liver metabolic pathways are developed and in second part transport and mass balance
equations in the two well mixed domains: tissue and blood, are developed to calculate
intermediate metabolite concentrations and fluxes in response to the changes in ethanol
and lactate concentrations in the perfusion medium. Part of the model without ethanol
metabolism has been validated and published in Chalhoub et al, 2007. The focus of this
effort was to illustrate the effect of ethanol metabolism on gluconeogenesis from lactate.
The kinetic models developed for phosphofructokinase and fructose 1,6 bisphosphatase
have been independently validated with data from the literature, whereas the results of the
comprehensive lumped model are compared with the data from Krebs et al (1969). While
the lumped model show many important characteristics of ethanol metabolism and
predicts the flux of glucose production in the same range, two major contradictions of the
simulated results with experimental data are observed. These shortcomings are discussed
with appropriate reasoning. The model presented in this thesis is expected to improve the
understanding on the effects of ethanol metabolism and provide a practical tool to address
alcohol related health issues.
iv
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CHAPTER I
INTRODUCTION
The mathematical model developed here attempts to provide a useful research tool
for understanding and predicting key characteristics of liver metabolism. The importance
of this effort is apparent from advantages such as quantifying intermediate metabolite
concentrations and fluxes in response to changes in various substrate concentrations.
Liver is one of the primary organs in vertebrates. The human liver is constructed of
approximately one million lobules, which essentially are the basic functioning units. Each
of these lobules consists of a hexagonal row of hepatic cells called hepatocytes. Two of
the major functions of liver are carbohydrate metabolism to generate energy, and removal
of toxic components by channeling them into metabolic pathways. This is achieved
through the metabolic reactions that take place in hepatocytes, and are controlled with a
very complex regulation through biological catalysts (enzymes). With over a thousand of
such metabolic reactions, each depending on number characteristics like concentration of
substrates and other metabolic intermediates and the activity of enzyme, developing a
model that can describe the complete in vivo behavior of liver is a challenge.
Ethanol has a large number of physiological repercussions. Alcoholism has been
reported as one of the leading cause for a number of health issues and diseases [35, 60,
1

61, 69]. Ethanol and its oxidation product acetaldehyde severely impair normal functions
of hepatocytes causing hypoglycemia, and alcoholic liver diseases such as hepatitis,
cirrhosis and fatty liver. Ethanol also affects other organs like brain, heart and kidney.
The only way to eliminate ethanol by the body is to metabolize it in the liver [35, 60, 61,
62]. Thus a model of liver metabolism which can also account for the effects of ethanol
metabolism can be of significant assistance to understand and treat diseases related to
alcohol.
This work has been divided in three parts based on specific aims. The primary
objective of our group was to develop a robust and realistic mathematical model
considering the organ as a lumped system (well mixed), validate it with the available data
in the literature to show its predictability, and confirm its usefulness by comparing the
response of the model to addition of ethanol with data in the literature. For this endeavor
important requisites were: sound understanding of intricate regulations of metabolic
processes to develop individual kinetic expressions for each important regulatory step
(which can allow us to grasp the in vivo characteristics in the comprehensive model),
transport kinetics for each metabolite between blood and tissue, and the dynamic mass
balances to predict the changes in concentrations and fluxes of metabolites with respect
to time.
Consequently, the first part of the thesis develops the kinetic expression for
phosphofructokinase and fructose 1,6-bisphosphatase, which catalyze two of the most
important regulatory steps in the glycolytic and gluconeogenic pathways. The second part
describes the selection of the kinetic expressions for alcohol and aldehyde dehydrogenase
which are the ethanol metabolizing enzymes. The third part incorporates these kinetic

2

models along with the complementary expressions for transport into a lumped model
which can account for the effects of ethanol metabolism.
In this work, the mechanistic kinetic expressions presented in the first two parts
are the quantitative description of enzyme regulation and function, in different hormonal
and nutritional states with high degree of generality. The lumped model developed with
the help of these expressions, along with the transport kinetics and mass balances
presents a promising tool for understanding and predicting fundamental processes in
metabolic system. Finally the investigation of the effect of ethanol on gluconeogenesis
demonstrates credibility of the model in physiological context. Successful comprehensive
models to this level of detail have not been formulated to date, which makes this a
distinguishing effort with a very worthwhile goal.

3

CHAPTER II
BACKGROUND
2.1 Mechanism of Ethanol Metabolism
Ethanol is an aliphatic (open chain) compound with low molecular weight. It is
completely soluble in water via the formation of intermolecular hydrogen bonds with the
hydroxyl groups of water. As a result of this complete solubility in water, ethanol can be
readily distributed throughout the body, crossing important biological membranes, such
as the blood brain barrier, to affect a large number of organs and biological processes
[66]. Ethanol is not known to be formed in the mammalian body nor it is present in any
of the natural food sources, therefore strong metabolic processes involving allosteric or
back regulation (such as for lactate, glucose) are absent [37, 39].

Ethanol taken via oral ingestion passes through the esophagus into the stomach
and small intestine, where it is absorbed into the bloodstream (approximately 20% from
stomach and 80% from small intestine). A very small fraction of ethanol can be
eliminated through lungs and kidneys. Since ethanol cannot be stored in the body, it must
be metabolized to be eliminated. Alcohol can only be metabolized in the liver, where
enzymes are found to initiate the process [36, 37, 45, 60]. Two pathways of ethanol
4

metabolism have been extensively studied in literature, (i) through the reactions catalyzed
by alcohol dehydrogenase (ADH) and (ii) through the Microsomal Ethanol Oxidizing
System (MEOS) [60, 61].

Figure 1. Possible metabolic pathways of ethanol metabolism [66].

A number of papers are published in the literature dealing with MEOS [60, 61,
62, 63, 64]. These papers can be divided in two groups: those where the ethanol oxidation
is believed to occur due to the unique enzyme system involving Cytochrome P450
(CYP2E1)[61, 63], and those which support the findings that the predominant mechanism
for ethanol metabolism is NADPH dependent hydrogen peroxide (H2O2) production (by
the microsomal electron transport) followed by the peroxidation of alcohol to
acetaldehyde by catalase[60, 62]. These mechanisms are shown in Figure 1. However,
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whether any of these systems functions in vivo or only in perfused organs, and the extent
of their contribution in total ethanol elimination is highly controversial. The MEOS
system consisting either of Cytochrome P450 or catalase is not inhibited by pyrazole,
which is a strong, competitive inhibitor of alcohol dehydrogenase. Inhibition studies of
alcohol dehydrogenase show a negligible rate of ethanol removal in liver for in vivo
conditions [36, 60, 61]. Also some of the findings strongly suggest that the generation of
reducing equivalence from alcohol dehydrogenation inhibits H2O2 generation leading to
significantly diminished rates of ethanol peroxidation via catalase [62]. Under the
conditions of chronic and high dosage of ethanol, catalase may play a small role, but even
under these circumstances the rate of removal of ethanol is very low as compared to that
of alcohol dehydrogenase. The reaction catalyzed by alcohol dehydrogenase (ADH) is
still considered the primary and most important pathway for ethanol metabolism. The
scope of this thesis is limited to the analysis of only this pathway for ethanol metabolism.
Important regulatory steps considered in the model are shown in Figure 2.

2.2 Effects of Ethanol Metabolism
Irrespective of the mechanism, ethanol is converted to acetaldehyde in liver, which
is then oxidized by aldehyde dehydrgenase (ALDH) to acetate. A fraction of acetate is
converted to acetyl CoA while more than 60% of acetate diffuses back into the
bloodstream [69]. The reactions catalyzed by ADH and ALDH each convert one NAD+
to one NADH, producing a significant imbalance in redox ratios, which disturbs a large
number of metabolic processes. The excess NADH affects the lactate to pyruvate ratios,
driving the equilibrium reaction towards lactate. Thus more pyruvate goes to lactate,
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which results in low gluconeogenic fluxes [35, 39, 40, 51, 53]. These pathways are
shown in Figure 2.

Figure 2. Metabolic pathways showing important regulatory steps in the comprehensive
model of ethanol metabolism.

Other major effects include triglyceride accumulation
accumulation, which subsequently results
in alcoholic liver cirrhosis. Excess NADH stimulates the synthesis of glycerol from
glycolytic
ic intermediates. Acetyl CoA accumulation increases the rate of ketone bodies
bod
production. High NADH concentration also inhibits enzymes of the TCA cycle, further
deteriorating metabolic functions. Acetaldehyde not converted to acetic acid can bind to
cysteine,
ine, a constituent of the anti
anti-oxidant peptide glutathione (GSH) which further
7

compromises liver mitochondrial functions with oxidative damage. Acetaldehyde
released into the bloodstream can drift to other organs like brain, where it can damage
proteins and DNA synthesis as well as lipid peroxidation in cell membranes [56, 66].

The aim of this thesis is to show the quantitatively effects of ethanol metabolism on
lactate to pyruvate ratio and gluconeogenic fluxe.

2.3 Previous Models of Ethanol Metabolism
A number of pharmacokinetic models of ethanol metabolism are described to
contribute to the understanding of ethanol clearance in human beings. Most of these fail
to account for acetaldehyde, which is an important toxic metabolite of ethanol
metabolism [41, 43, 44]. Fogler [45] presented a well-recognized, physiologically-based
pharmacokinetic model for ethanol and acetaldehyde metabolism. The model is highly
impressive in terms of their approach for modeling and compartmentation in which liver
is considered as tubular reactor while the stomach, gastrointestinal tract, central fluid, and
muscle are considered as well-stirred reactors. But their rate laws for alcohol
dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) are missing important
characteristics such as ethanol substrate inhibition, NADH product inhibition for ADH
and NAD+ control of ALDH. In all previous attempts of modeling ethanol metabolism,
no attempts were made to quantify the effects of ethanol on glucose metabolism and
lactate uptake.
In contrast to our lumped modeling approach, several authors have presented
other methodologies such as steady state flux balance analysis (FBA) in combination
with either Fischer discriminant analysis or optimization of a presumed objective
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function. All these models contain reactions describing hepatic metabolism which
provide insight into the distribution of fluxes over a range of steady states. All these
approaches use experimental measurements of fluxes as inputs. Absence of reaction
kinetics questions the reliability of these methodologies. A space - distributed modeling
approach is actually one of the best possible representation of liver metabolism, since it
accounts for the heterogeneity in enzyme distribution, differential flow rates, and
concentrations of metabolites across the liver. However, limited availability of
experimental data makes it nearly impossible to develop and validate a distributed model.

2.4 Role of PFK – FBPase Substrate Cycle
The reactions catalyzed by phosphofructokinase-1 (PFK) and fructose 1,6
bisphosphatase (FBPase) are the most significant step for controlling the relative rates of
glycolysis and gluconeogenesis. Tight control is accomplished through allosteric effects
(effect on the enzyme by species other than the substrate or product of the reaction at a
site other than the protein's active site) of fructose-2,6 bisphosphate (F2,6BP) and AMP
on both enzymes, substrate inhibition of PFK by ATP, and glucagon-controlled cAMPdependent phosphorylation of FBPase. These complex control mechanisms prevent the
simultaneous operation of both enzymes, which otherwise would lead to substrate cycling
and concomitant ATP hydrolysis.
Numerous kinetic studies of these two enzymes have been reported [3, 4, 11, 16,
18]. Most of these studies put emphasis on collecting in vitro kinetic data that reveal the
complex behavior of the enzymes and describe the binding pattern of the allosteric
activators and inhibitors. While each of these studies usually reported values for specific
kinetic parameters based on the experimental conditions investigated, comprehensive
9

quantitative models that consider the more recent knowledge of these enzymes, which are
necessary for a complete understanding of the coordinated regulation of the cycle, are
lacking. Furthermore, a realistic model should correctly predict the relative fluxes for a
wide range of substrate and allosteric effector concentrations. Moreover, these kinetic
models play key roles in comprehensive in silico models of liver metabolism under
development [33].

10

CHAPTER III
KINETIC MODELS OF
PHOSPHOFRUCTOKINASE AND FRUCTOSE-1,6BISPHOSPHATASE
3.1 Model Development
The most complete quantitative model of the regulation of PFK and FBPase ,
consisting of

detailed kinetic descriptions of the two enzymes, was developed by

Garfinkel before the discovery of F2,6BP and its important regulatory role in regulation
[18]. This work also did not include the effect of phosphorylation, which has been found
to be important in the regulation of FBPase.
The regulatory mechanism of PFK and early mathematical descriptions have been
reported by several groups. Brand and Soling [6] examined the kinetics of this enzyme
under conditions of very low ATP concentrations at pH 8 (where it did not exhibit any
allosterism) and calculated true Michaelis and inhibition constants based on an
approximate ordered bi bi reaction mechanism at low product concentration. Reinhart
and Lardy [30] studied kinetic activity of the enzyme under near-physiological
conditions. Since these studies were done before the discovery of F2,6BP, their models
11

lack this potent influence. The effect of F2,6BP was considered, along with calculation
of the Km for fructose-6-phosphate (F6P) and substrate inhibition by ATP, in a later
model of PFK by Reinhart [16]. However, this model did not include AMP activation
and its synergism with F2,6BP, resulting in an unrealistically large estimation of the half
velocity constant for F6P.
The allosteric regulation of FBPase has been modeled by means of a three state
binding model based upon the simple Monod equation [3]. However, no attempt was
made to compute the values for the parameters of the model. Francois et al. [4] also
proposed a model to describe the binding pattern of rat liver FBPase, but again the
parameter values were not computed.
The objective of the work presented here is to develop model equations that
exhibit the most important regulatory characteristics known of the two enzymes, PFK and
FBPase. These equations build upon previous models, especially that of Garfinkel, and
incorporate up-to-date information about the enzymes. Model parameters are calculated
using data from in vitro kinetic studies. With these comprehensive kinetic models,
simulations are performed to investigate and quantify the effects of various regulators on
cycling and net throughput through the F6P – F16BP system, and thus to better
understand the control mechanism for glycolysis and gluconeogenesis. Furthermore,
these kinetic expressions play key roles in our model of gluconeogenesis and lipid
metabolism in the liver.

3.1.1 Phosphofructokinase
PFK is subjected to strong metabolic control by a number of positive and negative
effectors that include fructose 1,6 bis-phosphate (F1,6BP), F2,6BP, AMP, MgATP, H+
12

and citrate. With detailed literature review we identified important kinetic characteristics
of PFK: 1) substrate inhibition of PFK by the high concentration of ATP; 2) activation by
F2,6BP; 3) activation by AMP; 4) interrelation between activation of PFK by F2,6BP and
AMP; 5) the fact that F2,6BP and AMP relives the inhibition of the enzyme by high
concentration of ATP [1, 2, 4, 11, 12]. These regulations are shown in Figure 3.

ATP
ATP

ADP

ADP

Inactive F2,6BPas
Active PFK-2

PFK-1

PEP

Glucose
H2O

+

+

Protein
Phosphatase

AMP

Pi

F6P
+
cAMP

ADP

Protein
Kinase

-

ATP

Active F2,6BPase
Inactive PFK-2
H2O

F1,6BP

F2,6BP

-

F1,6BPase
Pi
H2O

Pi

Figure 3 Regulation of PFK – FBPase substrate cycle with the bifunctional enzyme

Kinetic data suggested an ordered bi- bi reaction mechanism, with F6P as the first
substrate to attach, followed by ATP (which is an inhibitor as well), and ADP as the first
product to be released, followed by F1,6BP [6]. Since the products of the PFK reaction,
F1,6BP and ADP, play only a minor role in deciding the rate of reaction [1], we started
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with the approximat ordered bi-bi reaction mechanism at low product concentrations
assuming rapid equilibrium [15]:








 
   

    

  
(3.1)

Simplifying this expression further we proposed:
V
V

=

max

[ ATP ] ⋅ [F 6 P ]
K + [ ATP ] ⋅ [F 6 P ]

(3.2)

PFK has low affinity and high degree of cooperativity for its substrate F6P in the
absence of any effecter [6], based on this fact we raised F6P to the 2nd power as shown in
equation (3.3).
V
V

max

[ ATP ] ⋅ [F 6 P ]
2
K + [ ATP ] ⋅ [F 6 P ]
2

=

(3.3)

To enforce further regulation of substrate inhibition by ATP and activation by
F2,6BP and AMP, we modified the kinetic constant K in equation (3.3). The substrate
inhibition can be represented by a classical expression with assumption of rapid
equilibrium as [15]:


 
  

 




(3.4)

Using this equation for ATP substrate inhibition we modified the K of equation
(3.3). The complete substrate inhibition term of ATP, in equation (3.5) is raised to the 2nd
power to increase sensitivity of relative velocity of reaction to the high concentration of
ATP, resulting in:
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2

ATP ]
[
app 
+
K = K F 6 P  [ ATP ] + K
ATP
K

iATP







2

(3.5)

We selected equation used by Reinhart et al [16] to represent activation of the
enzyme PFK by F2,6BP and AMP concentrations. These equations are shown as terms T1
and T2 in equation (3.6) and (3.7). These terms, T1 and T2 are raised to the power n1 and
n2 respectively, to alter the sensitivity of activation by F2,6BP and AMP. Thus at high
F2,6BP concentration T1 à α/Q1 and at low F2,6BP concentration T1à α. Similarly at
low ATP concentration T2 à σ and at high AMP concentration T2 à σ/Q2. In these
expressions, α and σ are the extra binding constants and Q1 and Q2 are the coupling
parameters which describe the nature and magnitude of the effects of each allosteric
ligand on the binding of substrate F6P to enzyme. If Q < 1 the allosteric ligand is an
inhibitor, if Q > 1 the allosteric ligand is an activator, and if Q = 1 then the allosteric
ligand has no effect on substrate binding [16]. The dissociation constant for F2,6BP and
AMP in the absence of F6P is represented by KiF2,6BP and KiAMP respectively[16].

 K
+ [ F 2,6 BP] 

T1 = α  iF 2, 6 BP

[
]
2
,
6
+
K
Q
F
BP
1

 iF 2,6 BP

 K iAMP + [ AMP ] 

T2 = σ 
 K iAMP + Q 2 [ AMP ] 

n1

(3.6)

n2

(3.7)

F2,6BP is the most potent activator with a complex regulatory pattern. F2,6BP
(more prominently than AMP) relieves the substrate inhibition of ATP; this can be
described by the product of terms T1 and [ATP]2/KiATP. F2,6BP increases the affinity of
F6P for the enzyme, but has no effect on maximal activity of PFK. F2,6BP and AMP
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both individually and together overcome the inhibition by high concentration of ATP,
which can be achieved with the separate term (1 + T1 + T2). F2,6BP acts synergistically
with AMP to relieve ATP inhibition thus potentiating activation by AMP [9]. Both AMP
and F2,6BP act synergistically to decrease the half velocity constant for substrate F6P. To
account for all these effects we proposed an equation for half velocity constant K as:
2

2


ATP ] 
[
app 
+ T1
K = K F 6 P  [ ATP ] + K
 1 + T2 + T1
ATP
K

iATP 


(

)

(3.8)

The effect of phosphorylation on the kinetic properties of PFK is still an open
question [29], and has not been considered here. The influences of citrate, F1,6BP, and
ADP are also neglected since these interactions are less significant as compared to those
of ATP, AMP, and F2,6BP [1, 2, 16]. The complete model is shown in expression (3.9)

V
V

max

[ ATP ] ⋅ [F 6 P ]
2
K + [ ATP ] ⋅ [F 6 P ]
2

=

(3.9)

where
2

[
ATP ]
app 
+ T1
K = K F 6 P  [ ATP ] + K
ATP
K

iATP


 K iF 2 , 6 BP + [ F 2 , 6 BP ] 

T1 = α 

 K iF 2 , 6 BP + Q 1 [F 2 , 6 BP ] 
 K iAMP + [ AMP ]
T 2 = σ 
 K iAMP + Q 2 [ AMP



] 

2


 1+ T +T
2
1



(

)

(3.9.a)

n1

(3.9.b)

n2

(3.9.c)
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3.1.2 Fructose-1,6-Bisphosphatase
F2,6BP, a known powerful activator of PFK, is a strong inhibitor of FBPase. The
main characteristics of the enzyme are: the inhibition is much stronger at low substrate
concentration; inhibition of the enzyme by AMP is enhanced by F2,6BP (indicating
allosteric type inhibition), and F2,6BP changes the substrate saturation curve from almost
hyperbolic to sigmoidal [2,5,9,29]. Meek and Nimmo [3] have shown that F2,6BP can
bind at two distinct sites, catalytic and regulatory, and at high concentration of F2,6BP in
combination with high concentration of AMP, the kinetic response of the enzyme to
F1,6BP reverts to hyperbolic. Further they mentioned that inhibition of FBPase by AMP
is uncompetitive with respect to F1,6BP in the absence of F2,6BP, but non-competitive in
its presence. However, others [5,7] have shown that F2,6BP binds only to the catalytic
site with higher affinity than F1,6BP, which brings about a conformational change in the
enzyme that facilitates AMP binding. FBPase is also regulated by ADP and ATP, but
much higher concentrations of these nucleotides is needed than of AMP for a similar
effect [7].
The influence of phosphorylation on the activity of F1,6BPase has been a subject
of some dispute. Some groups have observed essentially no change in the activity of the
enzyme with phosphorylation [8,9], while others have detected increase in Vmax, and
decrease in apparent Km for substrate with phosphorylation [7,20]. FBPase is known to
be phosphorylated in vitro by cAMP-dependent protein kinase. It has been shown that the
unphosphorylated FBPase is more susceptible to inhibition by AMP and F2,6BP than is
the phosphorylated F1,6BPase [7,20]. In our model we accounted for the effect of
phosphorylation on the enzyme by considering the variations in the cAMP
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concentrations. The rat liver in vivo cAMP level is expected to vary from 0.008 mM in
fasted state to 0.0012 mM in the fed state [34].
Classical Monod, Wyman, and Changeux transition model (MWC Model) is
considered as the basis for developing this model for FBPase because of its ability to deal
with allosteric interactions and phosphosrylation [15]:






   !"#$
 '()!
%&    !"

where α = [s]/Ks, the substrate concentration to kinetic constant ratio,

The number of enzyme subunits, containing one catalytic site each, is
approximately represented by n. L is the allosteric constant – the equilibrium constant of
the free form of the low substrate affinity conformation of the enzyme (T-state) and the
high substrate affinity conformation (R-state).
The MWC model shown in equation (3.10) is then modified by introducing
additional terms for cAMP, AMP and F2,6BP:

α=

[F1,6BP]
[F2,6BP]
[cAMP]
[AMP]
,β =
,γ =
,σ =
K sF 1,6 BP
K iF 2 ,6 BP
K icAMP
K iAMP

In the absence of the inhibitors F2,6BP and AMP, phosphorylattion does not
affect Vmax of FBPase but in the presence of either of the inhibitors Vmax of FBPase is
appreciably different [7,20]. To account for this effect, the term is proposed as a
multiplier of Vmax in equation (3.10)

(1 + βγ

+ σγ )
T3 =
n
(1 + β ) (1 + σ ) n
n
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(3.11)

Both inhibitors F2,6BP and AMP act synergistically, with F2,6BP enhancing the
effect of AMP inhibition, This effect is represented by the product of the terms (1+ β )
and (1+σ) for F2,6BP and AMP in the denominator of (1 + βγ + σγ ) term.
F2,6BP is a competitive inhibitor and hence it must be also combined with the
allosteric constant L in the denominator of the MWC expression (3.10). Phosphorylation
of the enzyme by cAMP-dependent protein kinase increases the activity of the enzyme by
decreasing its apparent Km for F1,6BP. This can be achieved by dividing the allosteric
constant L by (1 + cγ ) , where the quantity c is the non-exclusive binding coefficient used
for controlling the extent of phosphorylation by cAMP. Thus the allosteric constant L of
the MWC expression is modified to:
L' = L

(1 + β ) n
(1 + cγ ) n

(3.12)

The final equation resulting from all these hypothetical arrangements, based on
understanding of the FBPase kinetic characteristics is shown in equation (3.13):

V
V max

α (1 + α ) n − 1
(1 + βγ + σγ
(1 + β ) n (1 + σ ) n
=
(1 + β ) n
L
+ (1 + α ) n
n
(1 + c γ )

)n

Where,
[AMP]
[ c AMP]
[F2,6BP]
[F1,6BP]
,σ =
,γ =
,β =
α =
K iAMP
K icAMP
K iF 2 ,6 BP
K sF 1 ,6 BP
L - Allosteric constant
c - Non-exclusive binding coefficient
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(3.13)

The sensitivity of the activity vi of each enzyme i, relative to each parameter Ki,j
in the kinetic model was defined as Svi,Ki,j, given by:

S vi , Ki , j =

∂v i v i
∂K i , j K i , j

(3.14)

The sensitivities were calculated using the central difference method, at concentrations
representative of the fed and fasted states.

3.2 Results
While numerous groups have obtained kinetic data on PFK from liver, the data
reported by Van Schaftingen et al. [1] is among the most comprehensive and includes
effects of F2,6BP and AMP. Moreover, their study was performed at near physiological
concentrations of metabolites, which is important if the model expression is to be
applicable in vivo. The kinetic parameters for PFK were obtained by fitting Eqn. 3.9 to
their data using the generalized reduced gradient method in microsoft excel. Parameter
estimation for Eqn. 3.13 (FBPase) was performed using in vitro kinetic data obtained by
Ekdahl et al. [20], with an emphasis on data obtained for physiological ranges of
metabolites. Estimated parameters and confidence intervals are shown in Tables I and II.
Table I Parameter values with confidence intervals in the PFK model (Eqn. 3.9).
α
σ
KATP (mM)
KappF6P (mM)
KiATP (mM)
n1
n2
KiF2,6BP (mM)
Q1
KiAMP (mM)
Q2

2
3.5
0.05
0.0007
1
3
3
0.03
100
2
50

+/- 1.88E+01
+/- 8.63E+01
+/- 1.77E+00
+/- 1.84E-03
+/- 2.05E+01
+/- 2.77E+01
+/- 5.64E+01
+/- 7.74E+00
+/- 2.65E+04
+/- 3.77E+02
+/- 1.04E+04
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Table II Parameter values with confidence intervals in the FBPase model (Eqn. 3.13).
KsF1,6BP uM
KiAMP uM
KiF2,6BP uM
KicAMP uM
L
n
c

1
182.20
30
20
2.76E+06
5.52
0.56

+/- 1.80e+000
+/- 1.35e+001
+/- 9.23e+000
+/- 6.60e+001
+/- 1.00e+007
+/- 1.69e+000
+/- Inf

The relative activities of PFK predicted by Eqn. (3.9) are shown in Figure 4 along
with the data obtained from the in vitro experiments. In general, the model captures the
important trends of the data as well as other known regulatory effects, in terms of
activation by F2,6BP ( Figure 4A-D), substrate inhibition by ATP (Figure 4B), activation
by AMP (Figure 4D), and hyperbolic dependence on the two substrates at high F2,6BP
concentrations (Figure 4A,C). At low concentrations of F2,6BP the model shows proper
cooperative behavior of the enzyme for substrate F6P (Figure 4A) and for F2,6BP as well
(Figure 4D).
Figure 4B shows the expected reduction of ATP-substrate inhibition by F2,6BP.
The synergism between activation by AMP and F2,6BP are demonstrated in Figure 4C.
While a very good correspondence between model and data are shown for most of the
concentration ranges, the model greatly underestimates activity at AMP greater than 0.4
mM and F2,6BP at 0.25 µM or less.

However, this region is at AMP concentrations

greater than that occurring in vivo ( 0.1 – 0.3 mM) [5,12,13,17,18], and at F2,6BP
concentrations in the low range of in vivo concentration (0.1 to 10 µM) [16,17], so
analyses using this model at in vivo conditions can be presumed to be valid. The
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interaction of F2,6BP with AMP, at more physiological concentrations, is demonstrated
in Figure 4D, with good correspondence between data and model.
Simulations of FBPase activity using Eqn. (3.13) are shown in Figure 5 in
comparison to in vitro data.

The inhibition by F2,6BP and the positive effect of

phosphorylation are captured almost perfectly, as shown in Figure 5A, which also
demonstrates that phosphorylation is ineffective at saturating concentrations of substrate.
The substrate-dependency is predicted well (Figure 5A,B,C), except at the
unphosphorylated state at high concentrations of F2,6BP, where no FBPase activity was
measured (Figure 5C).

Since FBPase is homotetramer [3,7,8], the expected value of n is

4, although the value that resulted in the best fit was actually 5.5, indicating that the
MWC model is not a rigorously correct description of the mechanism.
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Figure 4 Simulation results for phosphofructokinase kinetic model (Eqn.3.9).The in vitro
data used for developing the model with the corresponding model calculated outputs are
shown in the figure. Effect of F2,6BP on the affinity of PFK for substrate F6P (A) and on
inhibition of PFK by substrate ATP (B). Figures. (C) and (D) show effects of F2,6BP and
AMP on relative velocity of PFK. Simulation results are continuous lines, corresponding
experimental data are represented as points with the same color. Other metabolite
concentrations are as shown on the Figure. The data is from Van Schaftingen et al. [1].
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Figure 5. Simulation results for F1,6BPase model, Eqn. (3.13). The in vitro experimental
data (data points) along with the model calculated outputs (continuous lines) for FBPase
is shown in fugure. (A) Inhibition of rat liver phosphorylated and unphosphorylated
F1,6BPase by F2,6BP at two different concentrations of F1,6BP, 33 and 12.5 µM
respectively. (B) and (C): effects of AMP and F2,6BP on the flux of F1,6BPase at
different concentrations of substrate F1,6BP. (D) shows activity of phosphorylated and
unphosphorylated enzyme at different AMP concentrations. The cAMP concentration
used in the model results for phosphorylated enzyme is 0.0075 µmol/gww (16 µM) [34].
Other metabolite concentrations are as shown on the Figure The data are from Ekdahl et
al. [20].
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Simulations of the fluxes through PFK and FBPase at physiological
concentrations of metabolites, in the fed and fasted states, using Eqns (3.9) and (3.13),
are shown in Figure 6. Figure 6A shows the fluxes as a function of the ATP/ADP ratio,
where the total nucleotide concentration is kept constant. The two rates are relatively
independent of the ATP/ADP ratio near the value of 5.9 (measured in the cytosol in the
starved state [19]), indicating little control by this quantity at physiological conditions. As
expected, the rate of PFK is almost completely inhibited in the fasted state, while the flux
in the fed state is activated to 1.11 µmol/gww/min. Conversely, the FBPase is inhibited
in the fed state to 0.11 µmol/gww/min and activated in the fasted state to 0.89
µmol/gww/min. The net rate of glycolysis in the fed state is close to that measured in vivo
1.0 µmol/gww/min [ 23-27,31], with about 10 - 15 % of the carbon recycled through the
futile cycle. In the fasted state, the net rate of gluconeogenesis is 0.9 µmol/gww/min,
which is approximately double that expected for an in vivo 24 hour fasted state, [32] with
no futile cycling, which is in agreement with previous predictions [28].

These results

were calculated with the FBPase Vmax of 16 µmol/gww/min. The measured maximal
activity of FBPase from liver tissue actually has a large range (16 ±7 µmol/gww/min)
[22], which greatly influences the results obtained.
The regulatory effects of F2,6BP and AMP on the two enzymes are shown in
Figure 6C-D. It can be observed in Figure 6C that high concentrations of F2,6BP
relieves the substrate inhibition by ATP of PFK at physiological concentrations of all
other metabolites. This is a very important property of the enzyme behavior in vivo, as
mentioned earlier. Note that the greatest amount of futile cycling occurs in the mid-range
of F2,6BP concentration, with little futile cycling at the two extreme concentrations of
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F2,6BP. Figure 6D shows the effect of AMP on the fluxes. AMP also affects the amount
of futile cycling, with most cycling occurring at the lowest AMP concentration.
The sensitivities of PFK flux to the model parameters are shown in Figure 7A.
Under fasting conditions, the flux of PFK is very sensitive to changes in α, KiF2,6BP, KiATP,
Q1 and n1, while at the fed state the PFK flux is nearly insensitive to the same
parameters. Since the flux of PFK at the fasted state is negligible, the large sensitivities
at that state have no physical significance. Figure 7B shows that the model for FBPase is
highly sensitive to parameters n, KiAMP, and KicAMP. The terms in the MWC model for
FBPase (Eqn. 3.13) are raised to the power n, leading to the high sensitivity to this
quantity. The phosphorylation state of the enzyme strongly influences its activity, which
affects the extent of inhibition by KiAMP and KiF2,6BP and is affected by the cAMP
concentration relative to KicAMP.
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Figure 6 Simulations results for PFK and FBPase in fed and fasted states, Eqns. (3.9) and
(3.13).Species concentrations set equal to values representative of either the in vivo fed or the
fasted states. Fed state [AMP] = 180 µM [5,12,13,17,18], [F1,6BP] = 46 µM, [14,16,17],
[F2,6BP] = 10 µM,[16,17]. [F6P] =0.05 mM [14,18], [cAMP] = 1.2 µM, [34] Fasted state [AMP]
= 380 µM,[5,12,13,17,18]. [F1,6BP] = 55 µM, [15,16,17], [F2,6BP] = 0.1 µM,[16,17], [F6P]
=0.01 mM,[14,18] [cAMP] = 12 µM.[29]. Vmax for PFK = 3 µmol/gww/min,[21] Vmax for
F1,6Bpase = 16 µmol/gww/min.[22] (A) Fluxes as a function of ATP/ADP, keeping the
nucleotide sum constant; (B) fluxes as functions of ATP, with all other concentrations constant.
(C) Effect of different concentrations of F2,6BP on the fluxes of both the enzymes at different
concentrations of ATP. (D) Effect of different concentrations of AMP on the fluxes of both the
enzymes at different concentrations of ATP. Other metabolite concentrations are as shown on the
Figure
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FBPase enzymes in fed and fasted state.
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3.3 Discussion

The two model equations presented are based on the most up-to-date findings on
the regulatory characteristics of PFK and FBPase, and result in close correspondence
with in vitro kinetic data, especially for the conditions at the physiological concentrations
of metabolites. Although a lot of kinetic data on inhibition and half-velocity constants
have been published for these enzymes, the parameters have been reported for specific
conditions. Quantitative models for PFK and FBPase that integrate the major kinetic
effects, including more recent information such as the effects of F2,6BP on both enzymes
and the phosphorylation of FBPase, are not available. After the validation of each kinetic
equation, the model was then used to explore the effects of different regulators on the net
flux through the system and the expected extent of substrate cycling. The calculated flux
of gluconeogenesis is only 10% less than the experimental value in fasted state, this
demonstrate the reliability of the model.
PFK – FBPase is probably the most important control site for gluconeogenesis
and glycolysis with both short-term and long-term regulation by insulin and glucagon.
The increase in glucagon in the fasted state activates adenylyl cyclase, which results in
elevation of intracellular cAMP levels, which in turn activates cAMP dependent protein
kinase. The cAMP dependent protein kinase then catalyzes phosphorylation of the
bifunctional enzyme PFK2/F2,6Bpase and FBpase. The phosphorylation of the
bifunctional enzyme decreases F2,6BP levels because of activation of F2,6Bpase and
inactivation of PFK2 while the phosphorylation of FBPase later results in its increased
activity and hence increased flux of gluconeogenesis. The decrease in F2,6BP directly
deactivates PFK and activates FBPase further which again results in increased flux of
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gluconeogenesis. These changes also have a potent effect on the other substrate cycle,
PEP – pyruvate, since cAMP dependent protein kinase phosphorylates pyruvate kinase,
decreasing its activity. Also the decrease in F1,6BP level because of activation of FBpase
deactivates PK, both allostericaly ( F1,6BP is a strong activator of PK) and by making the
enzyme better substrate for phosphorylation by cAMP dependent protein kinase. Thus
the F6P – F1,6BP substrate cycle operated by the two enzymes not only affects the rate of
gluconeogenesis and glycolysis but also strongly regulates the PEP – pyruvate cycle.
We have accounted for the hormonal effects on PFK and FBPase through the terms for
F2,6BP and cAMP, and although they are set independently in the equations, they are
actually linked in vivo, as described above.
The statistical analysis of the two models was done to compute the confidence
intervals of the constants. These are reported in Table I and II. It can be observed that the
upper and lower limits of the confidence intervals are very large as compared to the
parameter values. We used two softwares: excel and matlab to calculate these confidence
intervals. Both programs gave the same results. This indicates the existence of singularity
which may result from interdependence of the model parameters. This means that the
values of the constants in the two kinetic models for PFK and FBPase are not uniquely
determined.
The basic aim of our effort to develop the kinetic models for these two enzymes
was to account for a number of important in vivo regulations. This could have been
achieved by using a complex polynomial expression that had constants with small
confidence intervals and exactly matched experimental data. But it is important to
recognize that the physiological significance of the model structure and parameter values

33

is of high importance. These expressions are critical part of our comprehensive model of
ethanol metabolism. Thus it is important to preserve the significance by keeping these
constants near the actual in vivo range of the respective substrate concentrations.
The model equations and parameters presented here are useful for understanding
metabolic regulation and predicting liver cell behavior when combined with the kinetic
descriptions of the other reactions in various pathways in the liver. A model of
gluconeogenesis and lipid metabolism in the perfused rat liver, that includes the kinetic
equations presented here, has been developed and shown to be predictive of the
intermediate concentrations and fluxes in response to perfusion with lactate, pyruvate,
and fatty acids. The PFK-FBPase model can be further improved by introducing other
known allosteric effectors, such as F1,6BP, ADP, and citrate for PFK, although we
expect that this will have little effect on the predictive ability of the in vivo model, since
these metabolites have a minor role in the regulation of PFK –FBPase. [1, 4, 31].
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CHAPTER IV
KINETIC MODELS OF ALCOHOL AND
ALDEHYDE DEHYDROGENASE
4.1 Alcohol Dehydrogenase
The physiological role of alcohol dehydrogenase in liver has been puzzling
because of the poor stereospecificity of the enzyme for its substrate. Alcohol
dehydrogenase catalyzes many reactions involving different types of alcohol, farnesol
and certain hydroxy and keto steroids. It has been suggested that oxidation of ethanol is
only an occasional activity while the major function of alcohol dehydrogenase is to
remove potentially toxic substrates, including ethanol, from circulation and channel them
into the pathway of energy supply [35, 36, 37].
As described in the first part of the thesis, in order to predict rates of ethanol
elimination at different ethanol concentrations and under different nutritional and
endocrinologic conditions we require knowledge of (1) total activity of alcohol
dehydrogenase, (2) the contents and specific activity of different forms of the enzyme, if
present, (3) kinetic mechanism and constants (i.e., the rate equation) and, (4) in vivo
concentration of substrates and products during ethanol metabolism.
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Kinetic behavior of alcohol dehydrogenase has been well studied and documented
over the last few decades. The reaction catalyzed by alcohol dehydrogenase is essentially
a cytosolic reversible reaction, involving substrates ethanol and NAD+ and products
NADH and acetaldehyde [41, 42, 43]:

CH3CH2OH + NAD

+

ADH

CH3CHO + NADH + H+

There are numerous factors which define the activity of this enzyme in vivo,
including age, sex, genetics, and the nutritional state of the body [35]. It has been
reported that activity of alcohol dehydrogenase falls to as low as 40% during fasting.
Although numerous isoenzymes of alcohol dehydrogenase have been reported (grouped
in Class I, II and III), their kinetic behavior is very similar to each other (70-90%
homology between the classes) [50]. Therefore, in this attempt isoenzymes of alcohol
dehydrogenase are not differentiated, and the activity of alcohol dehydrogenase is its total
activity. Alcohol dehydrogenase is found to be inhibited by high concentrations of its
substrate ethanol (above 10 mM) and product NADH. Factors influencing the rate of
ethanol removal are (1) activity of alcohol dehydrogenase, (2) reoxidation of NADH,
and., (3) NAD+, NADH and ethanol concentrations [42, 43, 57].

Figure 8. Ethanol metabolism with NADH reoxidation by malate – aspartate shuttle [59].
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Activity of alcohol dehydrogenase as motioned before varies significantly with
the nutritional state as well as during metabolism. As the alcohol dehydrogenase reaction
starts, it drastically alters redox ratios in cytosol, as NAD+ becomes limiting, high
concentrations of NADH produced must be reoxidized to NAD+ through the malate
dehydrogenase shuttle which takes place in mitochondria. Studies of ethanol metabolism
strongly suggest that these two factors, namely activity of the enzyme and reoxidation of
NADH, are the two most important factors in controlling the rate of ethanol elimination
[58, 59]. At high concentrations of ethanol and NADH, a ternary complex of ethanol –
ADH–NADH is formed which does not appreciably break down to an ethanol-ADH
complex and ultimately does not transform into products [43]. Thus the ADH reaction is
inhibited by high concentrations of ethanol and NADH. Other factors such as transport of
ethanol from blood to tissue are not considered important because of the complete
solubility of ethanol in water [57, 58, 59].
Based on these facts it can be concluded that ethanol elimination is approximately
zeroth order with respect to substrate, with substrate inhibition of ethanol and product
inhibition by NADH at their high concentrations. This type of behavior is best described
by the Theorell – Chance mechanism shown in Figure 9 and equation (4.1) [41, 42].
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Figure 9 Schematic of the Theorell-Chance mechanism [43].
Table III Kinetic constants of alcohol dehydrogenase model (Eqn. 4.1) [43].
Kb
Kq
Ka
Michaelis Constants µmol/ghep
Kp
Keq
Vf
MaximumVelocity µmol/ghep/min
Vr
Kib
Kiq
Kia
Inhibition Constants µmol/ghep
Kip
Ki
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480E-3
4E-3
33E-3
37E-3
1.94E-4
6.71
33.62
810E-3
0.9E-3
58E-3
12E-3
1.7E2

(4.1)

Crabb and Bosron [43, 44] extensively studied and justified the use of the
Theorell – Chance mechanism for alcohol dehydrogenase. Characteristics such as
substrate and product inhibition at their high concentrations making them important
regulators, formation of substrate-enzyme- product ternary complex, as well as dead-end
pyrazol inhibition are consistent with the Theorell – Chance mechanism. Kinetic
constants from the in vitro freeze clamped liver study on the fed and fasted animals are
reported in Crabbb - Bosron [43, 44]. Predictions of the rate of ethanol elimination using
those kinetic constants and a Theorell – Chance mechanism are found to be in agreement
with those found in vivo and are reported in the same publication.
Some authors have tried to describe the behavior of alcohol dehydrogenase with
ordered bi-bi reaction mechanism, which is approximately similar to the Theorell –
Chance mechanism, except for the last two terms in the denominator of equation (4.1)
[49]. At low concentrations of ethanol both mechanisms yield approximately the same
results but at high ethanol concentration (> 10 mM ), the Theorell – Chance mechanism
shows the important characteristic of substrate inhibition, which is missing in Ordered bibi reaction mechanism. For all these reasons we have selected the Theorell – Chance
mechanism for the estimation of the rate of the alcohol dehydrogenase reaction in the
next chapter of the thesis.

4.2 Aldehyde Dehydrogenase
Unlike alcohol dehydrogenase, which has isoenzymes with identical kinetic
constants and overall behavior (in fed and fasted states), isoenzymes of aldehyde
dehydrogenase have a very small homology and a strong differential intracellular
distribution between the different forms of the enzyme. These isoenzymes of aldehyde
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dehydrogenase are grouped into two classes based on their affinity for acetaldehyde as
high-Km aldehyde dehydrogenase (Km > 1 mM) and low-Km aldehyde dehydrogenase (Km
≤ 1 µM). Marjanen [42] reported that 80% of the total activity of aldehyde
dehydrogenase is found in the mitochondria while only 20% is found in the cytosol.
Moreover, most of the enzyme in the mitochondria is the low-Km aldehyde
dehydrogenase and the cytosolic enzyme is high-Km aldehyde dehydrogenase.
The reaction catalyzed by aldehyde dehydrogenase is essentially an irreversible
reaction involving substrates acetaldehyde and NAD+ and products NADH and acetate
[45, 46, 47]:

CH3CHO + H2O + NAD+

ALDH

CH3COOH + NADH + H+

The rate of acetaldehyde removal is controlled by the concentration of
acetaldehyde, the activity of the enzyme, as well as the NAD+ concentration available in
the respective intracellular compartment. At low acetaldehyde concentration, the NAD+
control is weaker, since enough concentration of NAD+ is available for the oxidation of
acetaldehyde. However, at high acetaldehyde concentration, NAD+ plays a significant
role in controlling the flux of ALDH reaction. During ethanol metabolism only a small
fraction of cytosolic NAD+ is available for acetaldehyde oxidation, since most of the
NAD+ is utilized for oxidation of ethanol. Svanas and Weiner [46], as well as Williamson
[47] reported that acetaldehyde oxidation in rat liver occurs almost entirely in
mitochondrial compartment at low to moderate concentrations of acetaldehyde. At high
acetaldehyde concentration, however, oxidation may take place in cytoplasm as well.
Nevertheless, the amount of acetaldehyde oxidized in mitochondrial compartment is
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always much higher than that occurring in cytoplasmic compartment; especially in case
of acetaldehyde from ethanol metabolism.
Based on these facts we concluded that a simple Michaelis – Menten equation
with some consideration to the NAD+ control should be enough to describe the kinetic
behavior of aldehyde dehydrogenase.

[

]
[


Vmax [S ] ⋅ NAD +
v ALDH = 
+
 (K m _ S + [S ]) ⋅ K m _ NAD + NAD

(





])

(4.2)

Where S = acetaldehyde

Table IV Kinetic constants of alcohol dehydrogenase model (Eqn. 4.2) [46].
Vmax

5.3 µmol/ghep/min

Km_s

3.40e-04 µmol/ghep

Km_NAD

0.00928 µmol/ghep

Svanas and Weiner [46] and Fogler [45] used a simple Michaelis –Menten
approach (rate of reaction regulated by the enzyme activity only) for estimating rates of
acetaldehyde metabolism. Fogler proposed an unsteady state, physiologically based
perfusion liver model to predict the rate of acetaldehyde elimination from ethanol in
different human body compartments – stomach, GI, liver and so forth. Svanas and
Weiner, on the other hand, used experiments with isolated mitochondria of rat
hepatocytes and a combined expression of two Michaelis –Menten equations for the low
and high Km acetaldehyde dehydrogenase to estimate the rate of disappearance of
acetaldehyde. The rates calculated by Svanas and Weiner at 200 µM acetaldehyde
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approximately matched with those found experimentally. Therefore, we used the same
kinetic constants estimated by Svanas and Weiner with the assumption that the
acetaldehyde is metabolized entirely in the mitochondrial compartment and that the
concentration of NAD+ also regulates the rate of acetaldehyde elimination.

4.3 Transport Mechanism for Ethanol and Acetate
The rate expression used for net transport of ethanol, acetate and other
metabolites such as glucose and lactate across the sinusoidal membrane is assumed to be
facilitated transport, given by:

J Etoh

J acetate

_ b _ t , net

_ b _ t , net

 V max, etoh ,b _ t ([ Etoh ]b − [ Etoh ]t )  
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(
)
K
+
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Etoh
]

m _ etoh _ b − t
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(4.3)

([acetate]b − [acetate]t ) 
V
=  max,acetate,b _ t


(K

m _ acetate _ b −t

+ [acetate]t )

(4.4)

The transport constants for expressions (4.3) and (4.4) are show in Table V. Vmax
and Km for the transport of both ethanol and acetate are obtained from the literature by
referring to the observed rate of ethanol and acetate elimination from blood in vivo [69].
Table V Kinetic constants for transport expression for ethanol and acetate.
Vmax,etoh,b_t

4.3 µmol/ghep /min

Km_etoh_b-t

0.1 µmol/ghep

From in vivo study [69]
Assumed based on expected ethanol
concentration in vivo

Vmax,acetate,b_t

4.04 µmol/ghep/min

Km_acetate_b-t

0.1 µmol/ghep

From in vivo study [69]
Assumed based on expected acetate
concentration in vivo
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CHAPTER V
MATHEMATICAL MODEL OF ETHANOL METABOLISM
IN LIVER
5.1 Model Development
The purpose of modeling individual kinetic reactions accurately in the previous
two sections (for phosphofructokinase, fructose 1,6-bisphosphatase and alcohol and
aldehyde dehydrogenase) was to obtain a reasonable flexibility and predictive power for
the estimation of concentrations and fluxes through each important regulatory step. This
is very crucial especially since significant recycling and complex regulation is involved
in these steps. Similar type of models were developed for other important reaction steps
like pyruvate kinase, pyruvate carboxylase and pyruvate dehydrogenase complex in our
group. Some of the simple, irreversible reactions are expressed with Michaelis – Menten
kinetics and introducing the ratios like ADP/ATP and NADH/NAD as relevant. With all
this detailed kinetic modeling and in-depth research on the complex regulation of
metabolism, we developed the basic building blocks for the lumped model of hepatic
metabolism.
The initial challenge was to confirm the effect of lactate and pyruvate perfusion
on the gluconeogenic fluxes and metabolite concentrations by comparing the calculated
43

results with the experimental data available from the literature. This part of the work has
been completed by coworkers (published in Chalhoub et al. 2007) [38]. The metabolic
pathways considered were glycolysis, gluconeogenesis, citric acid cycle, fatty acid
oxidation, fatty acid synthesis, ketogenesis, oxidative phosphorylation, and glycogen
degradation, with each pathway represented by a few key reactions, as shown in Figure 2.
Ethanol causes enormous turbulence in normal metabolic operations of hepatocytes. It
significantly affects almost all these pathways. Thus analyzing the response of the model
by adding the ethanol metabolism part can be used to validate the entire model, instead of
using different substrates which can stimulate only one pathway.
For the comprehensive lumped model of the perfused rat liver, tissue and blood
compartments are considered as two well mixed domains with mass balances for each
metabolite as show in equations (5.1), (5.2), (5.3). The mass balance in the tissue domain
is given by:
dCi ,tissue
dt

= J i ,b−t (Ci ,blood , Ci ,tissue )

Vtissue
+ ∑ Ri , j
Vsin usoid
j

The mass balance in the blood domain is given by:
Fperfusate
dCi ,blood
= (Ci , perfusate − Ci ,blood )
− J i ,b−t (Ci ,blood , Ci ,tissue )
dt
Vsin usoid

(5.1)

(5.2)

The mass balance in the perfusate is given by:
dCi , perfusate
dt

= (Ci ,blood − Ci , perfusate )

Fperfusate
V perfusate

Ci,perfusate - concentration of metabolite i in the perfusion medium (µmol / ghep).
Vperfuate - volume of the perfusion medium.
Fperfusate - perfusate flow rate through the liver.
J i,b-t - transport rate between the blood and tissue domains, (µmol / ghep min)
Ri,j - is the reaction rate of each reaction j with metabolite i as substrate or product
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(5.3)

Eq (5.1) and (5.2) are written only for those metabolites which are expected to
occur in blood (i.e. GLC, LAC, ALA, AcAc, BHB, PYR). The perfusion medium vessel
is also considered as well mixed system. The quantities Fperfusate and Vperfusate in Eqn. (5.1)
are assigned values that match the specific experimental conditions from the literature.
The rate mechanism for transport between the blood and tissue domains is
described by facilitated diffusion. Reversible near-equilibrium reactions (e.g. RGAPàPEP,
RLDH) are represented by a simplified form of a reversible, ping-pong mechanism, with
the Haldane equation used to relate kinetic parameters values at near-equilibrium and to
ensure consistency with thermodynamic constraints. The kinetic parameters were
generally obtained either from in vitro kinetic studies with purified enzymes, by
calculation from in vivo data and the assumed rate expression, or a combination of these
methods.
Redox ratios are significantly different in cytosolic and mitochondrial
compartments. Accounting for this difference is extremely important especially for
investigating effect of ethanol metabolism, since both the reactions for ethanol removal
involves NAD+ and NADH as substrate and product. We tried to address this issue by
establishing a pseudo-mitochondrial compartment for NADH/NAD+, with the assumption
that the mitochondrial redox ratio, RSm (defined as CNADH(M) / CNAD+(M)), is in
equilibrium with the cytosolic ratio RS (CNADH(C) / CNAD+(C)); this assumption is
expressed as RSm = Keq,RS · RS. The equilibrium constant Keq,RS is calculated from the
ratios of free cytosolic and mitochondrial CNADH /CNAD+ at the fasted steady state,
obtained from measurements of CLAC / CPYR and CBHB/CAcAc, respectively, at equilibrium
[38, 55, 58].
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Chapters III and IV describe individual kinetic models for important regulatory
steps like PFK – FBPase with their independent validation. For complete list of all the
kinetic models used in the lumped model along with their constants, please refer the
appendix of this thesis.
The lumped model with ethanol metabolism thus consist a total of 66 fluxes
which include transport and kinetics, 39 concentration terms of metabolites in blood,
tissue and perfusate and as a result 39 ordinary differential equations for mass balances.
The code was originally written in FORTRAN. As part of this thesis work, the code was
converted to MatLab and the 39 mass balances were solved simultaneously using MatLab
ordinary differential equation solver ode15s. We selected ode15s based on the
understanding of stiffness of the system, recognized during previous simulation runs on
FORTRAN.

5.2 Simulation Method
In this section results from the lumped model with infusion of ethanol metabolism
are discussed and compared to literature data.
Krebs [35, 36, 37] performed experiments with perfused rat liver to study the
effect ethanol on gluconeogenesis from lactate. The data published in Krebs et al (1969)
[35] is compared to the calculated results. In these experiments, he estimated the rate of
glucose formation at different initial ethanol concentrations and 10 mM initial lactate as
the recirculating single infusion. Accordingly, we set the initial concentration of lactate
in perfusion to 10 mM and the program was run using 6 different concentrations of
ethanol in the perfusion medium used by Krebs, shown in Table V. The initial conditions
used for other metabolites are shown in Table VII. These metabolite concentrations are
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from the initial lumped model without ethanol metabolism, validated with the data
obtained from Williamson et al [67].
The simulation is run over a time span of 0 to 130 min. Lactate and ethanol
perfusion begins at time t = 0 min. A single dose (pulse) of both substrates is added over
the entire time span. The recirculating perfusion method used is described [35]. Seven
separate sets of initial conditions were prepared. In each data set all the metabolite
concentrations are same except ethanol, which is increasing from 0 to 40, as used by
Krebs in his experiments. All these seven initial conditions are simulated separately, each
generating a comprehensive set of metabolite concentrations and fluxes with respect to
time. For this purpose a main MatLab program is written which can accept all these
initial conditions and run ode15s for each condition, solving 39 ordinary differential
equations for the mass balances along with their kinetic and transport equations for each
particular time step. A time-average over the simulated time span is calculated for all the
fluxes, similar to the method reporting in Krebs’ paper.
Table VI Ethanol and lactate concentrations added in perfusate for different initial
conditions used in simulation.

Experiment
No.
1
2
3
4
5
6
7

Initial Ethanol
concentration in
perfusion medium
mM
0
1.25
2.5
5
10
20
40
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Initial lactate
concentration in
perfusion medium
mM
10
10
10
10
10
10
10

Table VII Other initial metabolite concentrations used, common to all initial conditions
of (Table VI).

Metabolite

Concentration in
µmol/ghep

Metabolite

Concentration in
µmol/ghep

Glcucose_blood

0.46

Alanaine _blood

0

Glcucose_tissue

0.47

Acetoacetate_tissue

0.82

Lactate_blood

0

BHB

0.15

0

Pyruvate_blood

0

G6P

0.001

Acetoacetate _blood

0.80

Glycogen

108.01

BHB_blood

0.14

ATP

1.00

NH4

0.58

NADH

0.0001

F6P

0.0006

Pyruvate

0

F16BP

0.0007

AcCoA

0.009

Glcucose_perfusate

0.45

PEP

0

Acetoacetate _ perfusate

0.75

GAP

0

BHB_ perfusate

0.14

FFA

0.07

Etoh_blood

0

TG_tissue

3.74

Etoh_tissue

0

GLR_tissue

0

Acetaldehyde

0

GR3P

0

Acetate_blood

0

FFA_blood

-0.018

Acetate_tissue

0

GLR_blood

0.05

TG_blood

0

Alanaine_tissue

0.17

Lactate_tissue
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5.3 Results
Figure 10 (A) shows the flux of the reaction catalyzed by alcohol dehydrogenase
for the initial conditions of different ethanol concentrations as shown in the Table VI and
VII. It can be observed that the flux decreases around ethanol concentration 10mM. This
shows the important feature of the Theroll – Chance mechanism: the ethanol substrate
inhibition at high concentration (≤ 10 mM), discussed in Chapter IV. Numerous authors,
including Krebs, have pointed out this characteristic behavior of alcohol dehydrogenase
[35, 43, 44].
Figure 10 (B) shows the flux of the reaction catalyzed by aldehyde dehydrogenase
for the initial conditions (X-axis) used at different ethanol concentrations as shown in
Table VI. The substrate acetaldehyde is produced from the oxidation of ethanol; as a
result, the flux of aldehyde dehydrogenase reaction also shows similar trend as alcohol
dehydrogenase, shown in Figure 10 (A). Figure 10 (C) shows the rate of NADH
production. Since the change in the redox production rate is also triggered by oxidation of
ethanol. A similar trend can be observed by means NADH production.
Figure 10 (D), (E) and (I) show the net transport of ethanol and acetate from
blood to tissue. It can be observed that around 60 to 72% of the ethanol uptake by the
tissue is transported back into the blood as acetate. This is in agreement with
experimental results of 60 to 73% [53, 69]. Thus, only a small part of acetate is converted
in to acetyl CoA, while most of acetate is transported back into blood. This characteristic
is attributed to the fact that the high concentration of NADH produced during ethanol
metabolism strongly inhibits the enzymes the citric acid cycle: isocitrate dehydrogenase
and α-ketoglutarate dehydrogenase. [60, 61]
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Figure 10 Simulation results for the lumped model of liver metabolism with ethanol.
Weighted average of the flux over the time span 0 to 130 minutes is shown for each
initial condition mentioned in Table VI for different ethanol concentration. Figure [H]
show the ratio of flux of acetate released to the ethanol uptake, two horizontal lines show
the experimental range reported in Huang et al, [69]. Figure [I] show the comparison of
simulation results (bar) with experimental data (squares) from Krebs et al, [35].
Figure 10 (F) and (G) show the lactate uptake and the flux of the lactate
dehydrogenase reaction for different initial conditions shown in Table VI. No change was
observed in the simulation results of both these fluxes, which actually is contrary to the
expected results. Since lactate to pyruvate is a reversible reaction converting one NAD+
to one NADH, it is expected that as NADH concentration increases, the lactate
dehydrogenase reaction is driven towards lactate, converting more pyruvate into lactate.
Finally, Figure 10 (I) shows the rate of glucose production along with the
experimental data from Krebs. It can be observed that, even though the experimental
results and the calculated values are in the same range, the main characteristic of ethanol
metabolism inhibition of gluconeogenic flux in the fasted state, is actually missing. On
the contrary, simulation results show a slight increase in the glucose production for the
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initial ethanol concentration of 1.25, 2.5 and 5 mM. These apparent shortcoming are
discussed in the next section.
To address these inadequacies we performed manual parameter estimation for the
two important regulatory steps: reaction catalyzed by the enzyme pyruvate carboxylase
and conversion of PEP to GAP. The basis for selection of these two reactions is the fact
that both these reactions appreciably affect gluconeogenic fluxes and are significantly
influenced by the change in the redox ratios. The intention was to check the effect of
changes in the kinetic parameters of these regulatory steps on the average rate of glucose
production. The selection of the kinetic parameters from those two reactions was based
on their ability to alter sensitivity to redox ratios and the extent of initial approximation in
the model (those estimated using in vitro data). For the same ethanol concentrations and
simulation conditions the results are obtained by reducing the kinetic constant values by
10%, 50% and 90%. Results of this manual parameter estimation are shown in Figure 11
(A), (B) and (C). It can be observed that decreasing the maximum rate of the pyruvate
carboxylase reaction, decreases the average glucose production for all initial conditions.
This effect is significant if the Vmax is decreased to the 10% of its original value. But the
required characteristic of inhibition of gluconeogenic flux is not obtained. Changes in
kinetic constants for PEP to GAP reaction show only negligible effects on glucose
production flux.
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Figure 11 (A) Effect of change in Vmax_PC on glucose production flux [35].
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Figure 11 (B) Effect of change in Km_pep_gap on glucose production flux [35].
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Figure 11 (C) Effect of change in Km_gap_pep on glucose production flux [35].
Figure 11 Effect of selected kinetic constants on simulation results of glucose production.
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5.4 Discussion

The effect of ethanol metabolism on gluconeogenesis has been extensively
studied in literature. Most of the experiments estimated rates of glucose production from
various precursors such as alanine, glycerol, dihydroxy acetone, proline, galactose,
fructose and so forth [36, 39, 40, 57]. The initial lumped model (before addition of
ethanol metabolism part) was developed and validated considering the perfusion of
lactate to estimate the rate of glconeogenesis based on data published by Williamson et al
[67]. Accordingly, the basic aim of this thesis was to investigate the effect of ethanol
metabolism on gluconeogenesis from lactate. A redox imbalance results from the
oxidation of ethanol and acetaldehyde. On one hand high concentration of lactate drives
the LDH reaction towards pyruvate, also converting one NADH into one NAD+. On the
other hand the higher rate of NADH production from alcohol dehydrogenase drives
pyruvate towards lactate. Consequently, interpreting which of the control mechanism is
superior is difficult.
As a result, starting from lactate only as a substrate source, it becomes very
difficult to analyze and mathematically demonstrate the effect of ethanol on
gluconeogenesis. Unfortunately, the data available for our specific application is scarce.
Our results show almost no change in the lactate dehydrogenase flux and lactate uptake
with increasing concentration of ethanol. These results can be largely ascribed to the fact
that the model developed for the lactate dehydrogenase is not sensitive enough to changes
in redox ratios produced by ethanol metabolism at high lactate concentration (10 mM).
Additional shortcoming of this effort has been the contradiction of calculated
results with the experimental results that show inhibited rate of glucose production by
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ethanol. These numerical results can be attributed to the two steps in gluconeogenic
pathway: 1) the conversion of pyruvate to phosphoenolpyruvate (PEP) and 2) the
conversion of phosphoenolpyruvate to glyceraldehyde-3-phosphate (GAP). In the current
lumped model the conversion of pyruvate to PEP is represented by a lumped reaction
catalyzed by enzyme pyruvate carboxylase. While this is a reasonable approximation to
attain simplicity, while keeping the in vivo behavior achievable, in reality pyruvate is
converted to oxaloacetate by pyruvate carboxylase and oxaloacetate is converted to PEP
by enzyme PEPCK. Oxaloacetate is also part of citric acid cycle in which it is converted
to malate by the enzyme malate dehydrogenase. Furthermore, oxaloacetate is the highly
important part of malate aspartate shuttle, which ultimately is responsible for reoxidation
of NADH to NAD+ through the electron transport chain. Thus it can be concluded that in
the presence of ethanol it is difficult to lump the reaction for conversion of pyruvate to
PEP, neglecting further regulation of PEPCK and malate dehydrogenase.
The reaction catalyzed by pyruvate carboxylase is a highly important step in
gluconeogenesis. Flux of this reaction is strong function of pyruvate concentration. In the
presence of ethanol, lactate dehydrogenase reaction is inhibited because of high
accumulation of NADH and pyruvate produced from lactate dehydrogenase reaction is
extremely small. As a result, pyruvate carboxylase reaction is inhibited. Furthermore, as
pyruvate carboxylase reaction is inhibited no oxaloacetate is produced. Thus complete
malate – aspartate shuttle along with the electron transport chain is stopped. Because of
all these effects NADH reoxidation is not possible which further increases the inhibition
of all these reactions and ultimately inhibits the gluconeogenic flux. Figure 12 shows the
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reoxidation of NADH through malate dehydrogenase shuttle in the mitochondrial
compartment with the electron transport chain.

Figure 12.. Electron transport chain for reoxidation of NADH with malate dehydrogenase
shuttle[66].

Since the conversion of PEP to GAP is coupled with the oxidation of NADH to
NAD+, at high concentration of NADH the flux of PEP to GAP reaction increases,
resulting in increased flux of glucose production. Thus an increased flux through PEP to
GAP is triggered by the higher concentration of NAD
NADH, is shown in Figure 10 (I).
Currently the lumped model is constructed in two well mixed doma
domains: blood and
tissue. But in reality the intracellular compartmentation plays a vital role in cell
metabolism. Acetaldehyde dehydrogenase reaction, the malate – aspartate shuttle
responsible for NADH reoxidation, the complete TCA cycle including oxaloacet
oxaloacetate
reactions and the oxidative
xidative phosphorylation are th
the major controlling processes
influenced by compartmentation. We have tried to establish a pseudo compartmentation
using different NAD+ and NADH concentrations, but it was not enough to correctly
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simulate in vivo behavior. Establishing a formal mitochondrial compartment for
appropriate metabolites and reactions along with the regulations of oxidative
phosphorylation is important to analyze ethanol metabolism.
Irrespective of all these inadequacies, this thesis correctly shows the alcohol
dehydrogenase flux characteristics. The complete lumped model based on the kinetic
models developed for PFK, FBPase, ADH, ALDH and other enzymes predicts the
glucose production fluxes within the range of experimental results. This achieves the first
and foremost important step in establishing a framework for modeling fundamental
regulation of the liver metabolism. The shortcomings from the model are perceptible and
can be addressed in future work to bring the model one step closer to reality.
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CHAPTER VI
CONCLUSION
Lack of strong metabolic regulation for ethanol is attributed to the fact that
ethanol is not formed in mammalian tissue and nor it is present in any of the natural
resources of food. Still the effect of ethanol on metabolic system is severely deteriorating.
Our attempt has been not only to bring serious attention to these issues, but also to
present a practical option of using mathematical model to help address these issues in a
realistic way.
The kinetic models developed for the substrate cycle through PFK and FBPase are
acceptable quantitative description of in vitro experimental data and are based on the
latest findings on the enzymes. Even though the constants of these two models are not
uniquely estimated, the expected in vivo characteristics of the two enzymes were
demonstrated in the simulation results.
The lumped model presented in this thesis predicts the flux of glucose production
in the correct range as compared to the experimental estimations by Krebs. Two
important weaknesses can be identified from the results obtained; the model does not
show expected inhibition of gluconeogenic pathway and the lactate uptake along with the
lactate dehydrogenase flux remain unchanged for different ethanol concentrations.
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Kinetic models for lactate dehydrogenase and pyruvate carboxylase can be further
improved to obtain important regulatory characteristics of these enzymes exhibited at
high NADH concentration during ethanol metabolism. It can be easily noticed that most
of the alterations produced by ethanol are due to the changes in the redox ratios (to some
extent accumulation of acetyl CoA is also responsible). Consequently the model can be
further improved to a great extent by introducing a formal compartment for mitochondria
and kinetics of malate dehydrogenase. This will allow us to account for the differential
concentration and fluxes of metabolites across the mitochondrial membrane and enforce
the necessary regulation of redox and the electron transport chain to influence the
gluconeogenic fluxes. Once this model with mitochondrial compartment is established
with appropriate validation, it can be used to study effect of ethanol on ketone body
synthesis and fatty acid production.
With the recommended improvements to the model the simulated hepatic glucose
production at different ethanol concentration can be easily related to hypoglycemia
caused by alcoholism as well as other alcoholic liver disease. Thus importance of this
effort of modeling ethanol metabolism cannot be overstated.
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Table 1. Reaction rate stoichiometry, kinetic expressions, and parameter values used in the model. Definitions: PS=CADP/CATP;
RSm=CNADH(m)/CNAD(m)+;

For details please refer Chalhoub et al. (2007)
Rate

Kinetic Expression

Parameter Values

Parameters common to several
reactions:
PSi=0.44
RSi=0.2

A. Reaction Rates
RGK
69

GLC + ATP → G6P+ ADP

V max, GK C GLC

_t

K m , GK + C GLC

_t


1 / PS

 1 / PS i + 1 / PS





Vmax,GK =2.19 µmol gww hep1
min-1

KM,GK =6.25 µmol/gww hep

RG6Pase

V max, G 6 Pase C G 6 P

G6P→GLC

K m , G 6 Pase + C G 6 P

Method of
determining
parameters

Set equal to steady
state CADP/CATP
Set equal to steady
state
CNADH(m)/CNAD+(m)
Calculated from RGK
flux (from FBA,
assuming 30% cycling)
and steady state GLC
concentration
Set equal to steady state
GLC concentration

Vmax,G6Pase=3.65 µmol gww hep1
min-1

Calculated from RG6Pase

Km,G6Pase=0.102 µmol/gww hep

from FBA and steady
state G6P concentration
Set equal to steady state
G6P concentration

flux

RGI
G6P ↔ F6P

V max, G 6 P ,GI 
 C F 6P − C G6P
K eq ,GI
K m , F 6 P , GI 
C F 6P
CG6P
1+
+
K m , F 6 P ,GI
K m ,G 6 P ,GI

Vmax,G6P,GI =32.8 µmol gww hep-1min-1






Km,F6P,GI =0.046 µmol/gww hep
Km,G6P,GI =0.10 µmol/gww hep
Keq,GI=2.5

µ(1 + µ )n
(1 + βγ + δγ )n
n
n
(1 + β ) (1 + σ )
n
1+ β
n
LFBP
+ (1 + µ )
n
(1 + cFBPγ )
fgbp

Vmax,FBPase

RFBPase

fbp

(

fbp

fbp

)

FBP

fbp

F1,6BP → F6P
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µ=
γ=

CF1,6BP
KF1,6BP, FBPase
CcAMP
KicAMP, FBPase

;β =

;δ =

CF 2,6 BP
KiF 2,6 BP, FBPase
CAMP

KiAMP, FBPase

;

fbp

Vmax,FBPase=20 µmol gww hep-1min-1
KF1,6BP,FBPase=4.84E-04 µmol/gww hep*
KicAMP,FBPase=9.23E-03 µmol/gww hep*
KiF2,6BP,FBPase =1.56E-02
µmol/gww hep
KiAMP,FBPase=0.106 µmol/gww hep
nFBP=5.52
LFBP=2.76E+06
CFBP=0.56

Calculated from RGI
flux from FBA and
steady state F6P and
G6P concentrations
Set equal to steady state
F6P concentration
Set equal to steady state
G6P concentration
Calculated from in vivo
concentrations
Calculated from in vitro
kinetic data
*modified 10- 20% from
the original source.

V

RPFK

Vmax,PFK=3.75 µmol gww hep-1min-1
KATP,PFK=2.91E-02 µmol/gww hep
KiATP,PFK=0.058 µmol/gww hep
KiAMP,PFK=1.16 µmol/gww hep
KAPPF6P,PFK=4.0E-04 µmol/gww hep
KiF2,6BP,PFK=1.7E-02 µmol/gww hep
α =2.0
σ=3.5
n1=3.0
n2=3.0
Q1=100
Q2=50

2
ATP F6P

C ⋅C
=
2
V
KPFK+CATP⋅CF6P
max,
PFK

F6P + ATP → F1,6BP +
ADP

2



2
C


+T1n1 ATP  1+T2n2 +T1n1
C +KATP
,PFK K

,PFK
iATP


(

APP
F6P,PFK ATP

KPFK=K

)


K
+C
T1 =α iF2,6BP,PFK F2,6BP 

K
 iF2,6BP,PFK+Q1CF2,6BP

Calculated from in vitro
kinetic data.

K
+C 
T2 =σ iAMP,PFK AMP 

K
 iAMP,PFK+Q2CAMP

nPK −1
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Vmax,PKπ (1 + π + γ )

RPK
PEP + ADP → PYR + ATP

(1 + β ) (1 + κ ATP,PKγ )n
(1 + κ ALA,PK β )n (1 + φ )n
n pk

Lp

PK

PK

PK

π=

CPEP
C
; γ = ATP ;
K PEP,PK
K ATP,PK

β=

CALA
C
; φ = FBP
KiALA,PK
K FBP,PK

n

+ (1 + π + γ ) PK

Vmax,PK=62.5µmol gww hep-1min-1
KPEP,PK=3.2E-02 µmol/gww hep
KATP,PK=0.435 µmol/gww hep
KiALA,PK=1.16E-01µmol/gww hep
KFBP,PK=5.80E-04 µmol/gww hep*
Lp=1.60E+04
nPK=3.10
κΑΤP,PK=2.0
κALA,PK=0.2

Calculated from in vitro
kinetic data; modified
from the original source.

RLDH
LAC + NAD+ ↔PYR +
NADH

-1
-1
CPYRCNADH(c)  Vmax,LDH=195 µmol gww hep min
Vmax,LDH 
CLACC + −
 Km,LAC,LDH=1.43 µmol/gww hep
NAD (c )
Keq,LDH 
Km,LAC,LDH 
CLACCNAD+ (c) CPYRCNADH(c)
Km,PYR,LDH=4.77E-05 µmol/gww hep
1+
+
Km,LAC,LDH
Km,PYR,LDH

Keq,LDH=1.1E-04

RALA→ PYR
ALA + NAD+ → PYR+
NADH
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C C
Vmax,ALA,PYR 
 CALAC + − PYR NADH(c ) 
NAD
c
(
)
Keq, ALA,PYR 
K m, ALA,PYR 
CALACNAD+ (c ) CPYRCNADH(c )
1+
+
K m, ALA,PYR
Km,PYR, ALA

Vmax,ALA,PYR=300 µmol gww hep-1min-1

KmALA,PYR=0.71 µmol/gww hep
Km,PYR,ALA=2.4E-07 µmol/
gww hep
Keq,ALA,PYR=2.5E-03

Vmax,PC

RPYRàPEP
PYR + ATP + GTP →
PEP + ADP + GDP + Pi +
CO2

1+

K ATP, PC
C ATPn

+

Vmax,PC=12.4 µmol gww hep-1min-1
KATP,PC=0.034 (µmol/gww hep)^1.03
KPYR,PC=7.1 (µmol/gww hep)^0.8
KiADP,PYR,PC=1.74 µmol/gww hep
KiADP,ATP,PC=0.521 µmol/gww hep

1


C ADP

1 +

 K
i , ADP, PYR, PC 

K PYR,PC

1 PC

CPYR




1 + K
i , ADP, PYR, PC 


n2 PC 


ϖ

C ADP

Ka,AcCoA,PC=2.28E-05 (µmol/gwwhep)^1.65

n1,PC =1.03




K ATP
C ADP
1
+
ϖ =
n
n
K


C
C
i
ADP
ATP
PC
,
,
,

ATP
AcCoA

+
1
 K

a , AcCoA, PC 

3 PC

1 PC

 n2,PC =0.80

 n3,PC =1.65





in vitro
Set equal to product of
steady state LAC and
NAD+(c) a
concentrations
Calculated from in vivo
LDH flux15 and steady
state LAC, PYR,
NAD+(c)a, and NADH(c)b
concentrations
in vitro
in vitro
Set equal to product of
steady state ALA and
NAD+(c)a concentrations
Calculated from in vivo
flux15 and steady state
ALA, NAD+(c)a , PYR
and NADH(c)b
concentrations
In vitro
Calculated from in vitro
kinetic data for pyruvate
carboxylase

-1

RPEP ↔ GAP
PEP + ATP + NADH↔
GAP + ADP + NAD+

-1

CGAPCPiCNAD+(c)CADP Vmax,PEP,GAP =94.0 µmol gwwhep min
Vmax,PEP,GAP
CPEPCNADH

(c)CATP−
Keq,PEP,GAP  Km,PEP,GAP =4.3E-05 µmol/gww hep
Km,PEP,GAP
C C C +(c)CADP
Km,GAP,PEP=9.13E-03 µmol/
CPEPCNADH
(c)CATP GAP Pi NAD
+
1+
gww hep
Km,PEP,GAP
Km,GAP,PEP
Keq,PEP,GAP=4166
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RGAP↔F1,6BP

V max, GAP , F 1, 6 BP C GAP

GAP↔F1,6BP

K m ,GAP , F 1, 6 BP + C GAP

Vmax,GAP,F1,6BP =
4.97 µmol gwwhep-1min-1

Km,GAP,F1,6BP =0.0194 µmol/gww hep

Vmax,PDCCPYR

RPDC
PYR + NAD+ → AcCoA +
NADH

RFFA → AcCoA
FFA + 2ATP + 7NAD+ +
7FAD→
8AcCoA + 7NADH +
7FADH +
2ADP

C
2
1+βPDC AcCoA+δPDC(RSm) (KPDC+CPYR)
1+
CCoA
 PS 

 αPDC

Vmax,PDC =
1.88 µmol gww hep-1min-1
KPDC=0.20 µmol/gww hep
α,PDC = 0.9
β,PDC = 25; δ,PDC = 0.50
Vmax,FFA,AcCoA=
6.76 µmol gww hep-1min-1

Vmax,FFA,AcCoA
CFFA 1/ RSm  1/ PS 



Km,FFA,AcCoA+CFFA1/ RSi, +1/ RSm 1/ PSi, +1/ PS K
m,FFA,AcCoA =0.36 µmol/gww hep

In vitro
Set equal to product of
PEP, NADH(c)b, and
ATP concentrations,;
modified during
parameter estimation
Calculated from RPEP ↔
GAP

flux from FBA and
steady state PEP, ATP,
NAD+(c)a, NADH(c)b,
GAP, and ADP
In vitro
Calculated from

RGAP↔F1,6BP
flux from FBA and
steady state GAP
concentration
Set equal to steady state
GAP concentration57,66
Calculated from in vitro
kinetic data

Calculated from in vivo
flux, steady state FFA,
PS, and RSm
concentrations
Set equal to steady state
FFA concentration

RTG→FFA

V max, TG , FFA C TG ,t

Vmax,TG, FFA =

K m ,TG , FFA + C TG ,t

3.67 µmol gww hep-1min-1
K m,TG, FFA =0.0071 µmol/
gww hep

RGLR_t→GR3P
GLR+ATP→GR3P+ADP

Vmax,GLR,GR3PCGLR,t 

1/ PS


Km,GLR,GR3P + CGLR,t  1/ PSi + 1/ PS 

Vmax,GLR,GR3P =
0.79 µmol gww hep-1min-1

K m,GLR,GR3P = 0.125 µmol/
gww hep

74

RGR3P↔GAP
GR3P+NAD+↔GAP+NAD
H


C C
Vmax,GR3P,GAP
CGR3PC + + − GAP NADH(c) 
NAD(c)
Keq,GR3P,GAP 
Km,GR3P,GAP
CGR3PCNAD+(c) CGAPCNADH(c)
1+
+
Km,GR3P,GAP Km,GAP,GR3P

Vmax,GR3P,GAP=
115 µmol gww hep-1min-1
Km,GR3P,GAP=0.47 µmol/gww hep
Km,GAP,GR3P=7.06E-07 µmol/gww hep

Keq,GR3P,GAP=1.3E-04

Calculated from

RTG→FFA
flux from FBA and
steady state TG,t
concentration
Set equal to steady state
TG,t concentration
Calculated from in vivo
flux and steady state PS
and assumed GLR,t
concentrations.
Set equal to the assumed
steady state GLR,t
concentration
in vitro
Set equal to product of
steady state GR3P and
NAD+(c)a concentrations
Calculated from

RGR3P↔GAP
flux from FBA and
steady state GR3P,
NAD+(c)a, NADH(c)b,
and GAP concentrations
In vitro

RFA_syn

Vmax, FA _ syn =2.7 µmol

8AcCoA + 7ATP →
FFAc16 + 7ADP

Vmax,FA_ synCAcCoA 

1/ PS


Km,FA_ syn + CAcCoA 1/ PSi + 1/ PS 

-1

-1

gww hep min

K m , FA _ syn =0.13 µmol/gww
hep

RTG_f
3FFAc16 + 2ATP + GR3P →
TG + 2ADP

ε =0.75

Calculated from RTG_f
flux from FBA and steady
state FFA concentration
Set equal to the product of
steady state FFA14 and
GR3P concentrations.
Calculated from in vivo
flux and steady state
AcCoA concentration.
Derived previously.

Vmax, AcCoA _ AcAc C AcCoA

Vmax, AcCoA _ AcAc =

Calculated from

K m , AcCoA _ AcAc + C AcCoA

9.28 µmol gww hep-1min-1
K m , AcCoA _ AcAc =0.124

Vmax,TG− f CGR3PCFFA 

1/ PS


Km,TG− f + CGR3PCFFA  1/ PSi + 1/ PS 

Vmax,TG − f =
-1

-1

0.43 µmol gww hep min
K m,TG − f =0.11 µmol/gww
hep

RTCA

+

8AcCoA+ADP +3NAD +
FAD→
16CO2 + ATP + 3NADH
+FADH
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RAcCoA→AcAc
2AcCoA→AcAc+2Co
A



1 / RSm
1 / PS

Vmzx,TCAC AcCoA ε
+ (1 − ε )
 1 / RS + 1 / RS
1 / PSi, + 1 / PS 
i,
m


Vmax,TCA=
22.33 µmol gww hep-1min-1

µmol/gwwhep
Vmax, AcAc _ BHB =

RBHBdh
AcAc + NADH↔BHB +
NAD

Calculated from RFA_syn
flux from FBA and steady
state AcCoA concentration
Set equal to the steady state
AcCoA concentration.

C C +
Vmax,AcAc_ BHB 
 CAcAcCNADH(m) − BHB NAD (m)
Keq,BHBdh
K m, AcAc_ BHB 
CAcAcCNADH(m) CBHBCNAD+ (m)
+
1+
Km, AcAc_ BHB
K m,BHB_ AcAc






60 µmol gww hep-1min-1
K m , AcAc _ BHB =0.0071µmol/
gww hep

K m , BHB _ AcAc =0.0059µmol/
gww hep

K eq , BHBdh =20

RAcCoA→AcAc
flux from FBA and steady
state AcCoA concentration
In vitro
Set equal to product of
steady state concentrations
of AcAc and NADHm
(assumed = 0.01 µmol
gww-1 hep)
Calculated from RBHBdh
flux from FBA and steady
state substrate
concentrations
in vitro

Vmax,OxPhos=
37.8
µmol gww hep-1min-1


ROxPhos
O2 + 5ADP + 2NADH →
2H20 + 5ATP +2NAD+

Rurea
2NH4+HCO3+3ATP→
urea+2ADP+2Pi+AMP+P
Pi

Vmax, OxPhos C O 
PS

K m , OxPhos + C O  PS + PS i
2

2


RS m


 RS i + RS m  Km,OxPhos=7.3 µmol/gww hep
Vmax,urea=2.57 µmol gww hep1
min-1

V max, urea C NH 4 

1 / PS


K m ,urea + C NH 4  1 / PS i + 1 / PS 

Km,urea=0.70 µmol/gww hep

RGlycàG6P

(Glyc)n à (Glyc)n-1 +
G6P

-1

-1

RGlycàG6P= 0.0358 µmol gww hep min

Calculated from ROxPhos
flux from FBA and steady
state O2 concentration
Set equal to the steady state
O2 concentration
Calculated from Rurea flux
from FBA and steady state
NH4+ 7 concentration
Set equal to steady state
NH4+ concentration
Set equal to in vivo flux

B. Transport Rates
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JGLC,b-t,net

Vmax,Glc,b−t (CGlc,b − CGlc,t )
( K m,Glc,b−t + CGlc,b + CGlc,t )

Vmax,Glc,b_t=
17.8 µmol gww hep-1min-1
Km,Glc,b_t=5.07 µmol/gww hep

JLAC,b-t,net

Vmax,Lac,b−t (C Lac,b − C Lac,t )
( K m,Lac,b−t + C Lac,b + C Lac,t )

Vmax,LAC,b_t=
22.5 µmol gww hep-1min-1
Km, LAC,b_t=1.2 µmol/gww hep

JFFA,b-t,net

Vmax,FFA,b−t (C FFA,b − C FFA,t )
( K m,FFA,b−t + C FFA,b + C FFA,t )

Vmax,FFA,b_t=4.7 µmol gww hep1
min-1
Km,FFA,b_t=0.67µmol/gww hep

Calculated from in vivo
flux and steady state GLC,b
concentration
Set equal to steady state
GLC,b concentration
Calculated from in vivo
flux and steady state
LAC,b concentration
Set equal to steady state
LAC,b15 concentration
Calculated from in vivo
flux and steady state FFA,b
concentration
Set equal to steady state
FFA,b15 concentration

JGLR,b-t,net

Vmax,GLR,b−t (CGLR,b − CGLR,t )
( K m,GLR,b−t + CGLR,b + CGLR,t )

Vmax,GLR,b_t=
2.53 µmol gww hep-1min-1
Km,GLR,b_t=0.16 µmol/gww hep

JTG,b-t,net

Vmax,TG,b−t (CTG ,b − CTG,t )
( K m,TG ,b−t + CTG,b + CTG,t )

Vmax,TG,b_t=
0.044 µmol gww hep-1min-1
Km,TG,b_t=0.4 µmol/gww hep

JALA,b-t,net

Vmax,ALA,b−t (C ALA,b − C ALA,t )
( K m, ALA,b−t + C ALA,b + C ALA,t )

Vmax,ALA,b_t=12 µmol gww hep1
min-1
Km,ALA,b_t=0.56 µmol/gww hep
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JBHB,b-t,net

Vmax,BHB,b−t (C BHB,b − C BHB,t )
( K m,BHB,b−t + C BHB,b + C BHB,t )

Vmax,BHB,b_t=
2.64 µmol gww hep-1min-1
Km,BHB,b_t=0.85 µmol/gww hep

Jpyr,b-t,net

Vmax,PYR,b−t (C PYR,b − C PYR,t )
( K m, PYR,b −t + C PYR,b + C PYR,t )

Vmax,PYR,b_t=8 µmol gww hep1
min-1
Km,PYR,b_t=0.062 µmol/gww hep

JAcAc,b-t,net

Vmax, AcAc,b − t (C AcAc,b − C AcAc,t )
( K m , AcAc,b − t + C AcAc, b + C AcAc, t )

Vmax,AcAc,b_t=
34.8125 µmol gww hep-1min-1
Km,AcAc,b_t=0.7 µmol/gww hep

Calculated from in vivo flux
and steady state GLR,b
concentration
Set equal to steady state
GLR,b concentration

Calculated from flux from
FBA and steady state TG,b
concentration
Set equal to steady state
TG,b concentration
(assumed)
Calculated from in vivo flux
and steady state ALA,b
concentration
Set equal to steady state
ALA,b concentration
Calculated from in vivo flux
and steady state BHB,b
concentration
Set equal to steady state
BHB,b concentration
Calculated from in vivo flux
and steady state PYR,b
concentration
Set equal to steady state
PYR,b15 concentration
Calculated from in vivo flux
and steady state AcAc,b
concentration
Set equal to steady state
AcAc,b concentration

Table 2. Steady state results, at the overnight fasted state, experimental and calculated, with upstream blood concentrations given here: C*Glc= 4.6
C*AcAc=0.43 mM; C*BHB= 1.2 mM; Fblood =6.57 ml/min ; Vtissue=5.25 cm; Vblood
mM; C*LAC=1.7 mM ; C*PYR=0.12mM; C*FFA=1.5 mM;
3
=1.03 cm . Reaction rates (Ri) and transport rates (Ji,b-t) are given in Table 1 (+: production rate, -: uptake rate). For details please refer Chalhoub

et al. (2007)
Metabolite Concentrations µmol gww hep-1
Calculated Experimental

Fluxes µmol gww hep-1min-1
Calculated Experimental
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Glc,tissue
Glc,blood
F6P
F1,6BP
G6P
glycogen
GAP
GR3P
PEP
PYR,blood
PYR,tissue
LAC,blood
LAC,tissue
AcAc,blood
AcAc,tissue
BHB,blood
BHB,tissue
ALA,blood
ALA,tissue
AcCoA
ATP

6.3
5.55
0.039
0.0023
0.087
109
0.015
0.25
0.0061
0.024
0.023
0.59
0.46
1.47
1.61
2.07
5.6
0.23
0.18
0.13
3.46

4.5-6
5.07-5.48
0.046
0.016
0.102
109-175
0.021
0.31
0.05
0.062
0.059
0.85-1.2
0.35-0.95
0.68-0.99
0.5-0.78
0.85-1.7
2.23
0.5
0.47
0.13
3.43

JGLC,b-t,net
JLAC,b-t,net
JBHB,b-t,net
JALA,b-t,net
JPYR,b-t,net
JFFA,b-t,net
JGLR,b-t,net
GK
G6Pase
GI
GAPàF1,6BP
FBPase
PFK
PEPàGAP
PK
PYRàPEP
LDH
GLRàGR3P
GR3PàGAP
FAT_syn
FFAàAcCoA

1.11
-1.38
1.09
-0.59
-0.12
-0.87
-0.96
0.57
1.68
1.07
2.15
1.08
0.007
2.08
0.0003
2.09
1.26
0.099
0.06
0.71
0.86

ATP+ADP+AMP
NADH(m)/NAD(m)+
NADH(c)/NAD(c)+

5.07
0.25
0.0021

3.68-5.2
0.18
0 .0017

TG_f
AcCoaàAcAc
OxPhos
TCA
JTG,b-t,net
PDC

0.11
4.83
8.20
1.37
0.03
0.0023

1.2-1.9
-1.54
0.93
-0.64
-0.14
-0.8
-0.14

5.56
3-3.6, 7.9

1.7

Table 3. Initial conditions and input functions used in simulation of the perfused liver. (RFA-endo=rate of endogenous fatty acid
oxidation, normalized to µmol C16 (palmitate); JFA-b-t = the sum of the uptake rate of FFA and rate of endogenous fatty acid oxidation).
For details please refer Chalhoub et al. (2007)

Initial
Lactate
perfusion conditions used
in Eqn. 4
Ci,perfusate (t=0) =0;
i=Glc, LAC,
BHB, AcAc
(saline preperfusion
contains no
substrate)

Saline pre-perfusion;
0 < t ≤ 30

Lactate infusion;
30 < t ≤ 60

Lactate + FA;
60 < t ≤ 90

RFA-endo = 0.105
µmol gww hep-1min-1,
assumed to be equal to
experimental
measurements of ketone
production during this
period65.

RFA-endo = 0.0573
µmol gww hep-1min-1, as
estimated65 from ketone
production.

J*FA-b-t=
0.0573+0.27(1-exp(-(t-60) /τ),
τ=2.5 min; total rate of 0.33 µmol
gww hep-1min-1 determined from
experimental measurements of
oleate infusion65.
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Pyruvate Initial
perfusion conditions used
in Eqn. 4
Ci,perfusate (t=0) =0;
i=Glc, LAC,
BHB, AcAc,
PYR
(saline preperfusion
contains no
substrate)

CLAC,,perfusate =
10(1-exp(-(t-30)/τ) mM
(constant LAC
concentration of 10 mM in
perfusate); τ is time
constant for achieving
change in susbstrate
concentration, set to 4 min.

CLAC,,perfusate =10 mM

Saline pre-perfusion;
0 < t ≤ 30

Pyruvate infusion;
30 < t ≤ 90

Pyruvate + FA;
90 < t ≤ 120

RFA-endo = 0.105
µmol gww hep-1min-1

RFA-endo =0.0573
µmol gww hep-1min-1
CPYR,,perfusate =
2(1-exp(-(t-30)/ τ) mM
(constant PYR
concentration of 2 mM in
perfusate); τ=3 min.
CLAC,,perfusate calculated from
Eqn. 3.

J*FA-b-t =
0.0573+0.27(1-exp(-(t-60) / τ),
τ=2.5 min; experimental FA uptake
not reported; assumed equal to data
from lactate perfusion.
CPYR,,perfusate =2 mM

